Navigation Links
Tegra Medical Appoints New Chief Executive Officer
Date:1/15/2014

BOSTON, Jan. 15, 2014 /PRNewswire/ -- Tegra Medical is very pleased to announce the appointment of Mr. J. Mark King as its new Chief Executive Officer.  Mark was promoted from his current role of Chief Operating Officer, in which he has overseen the company's four facilities in Massachusetts, Mississippi, and Costa Rica.  Mr. King joined Tegra Medical in 2012 with 20+ years of broad-based operations, sales, engineering and manufacturing experience in medical device businesses, both in branded product lines and in contract manufacturing.  Prior to joining Tegra, Mark was President and CEO of Clinical Innovations, a market leader in women's health medical devices.  During his career, he has held leadership positions with several other related companies, including Baxter Healthcare, Cardinal Health and Johnson and Johnson.  Mark is a Six Sigma Green Belt.

"I am eager to continue the operational progress we have achieved at Tegra so that we can serve our customers well," said King.  "Tegra Medical remains committed to developing and manufacturing products for our top-tier medical devices partners that improve healthcare outcomes for clinicians and their patients worldwide.  Our employees strive to exceed our customers' expectations each and every day.  They take great pride and ownership of our business, with which I am proud to be associated."

"We are very excited to promote Mark to CEO of Tegra Medical.  As the Chief Operating Officer of Tegra, Mark has demonstrated tremendous leadership, commitment and execution.  I am confident that Mark will provide complete continuity for our customers and employees and that he will continue to lead Tegra's efforts to deliver operational excellence for our customers," said David Belluck, Chairman of the Board of Tegra Medical and General Partner of Riverside Partners. 

About Tegra Medical:
Tegra Medical is focused exclusively on the medical device industry, providing precision machining, molding, assembly and contract manufacturing services.  Tegra uses a wide range of manufacturing technologies to produce complex components and finished devices used in cutting-edge procedures for the leading OEM's.  Tegra has 200,000 sq. ft. of modern manufacturing space in four locations (including international) and is FDA and ISO 13485:2003 registered.  The company combines a broad spectrum of capabilities with a can-do culture to deliver exceptional solutions, speed and service.  Tegra Medical has provided premium quality contract manufacturing and assembly services for the medical device industry for over 20 years.  Our markets include:

  • Orthopaedics – including arthroscopy, spine, interventional spine, trauma, and joint and dental reconstruction
  • Minimally-invasive surgery – including breast biopsy, laparoscopy, endoscopy, soft tissue repair, cardiovascular, gynecology, and interventional spine
  • Interventional therapies – including radiology, cardiology, neurology, peripheral vascular therapy, and electrophysiology
  • Other medical areas – such as diabetes, drug delivery, opthalmology and dental that require a high level of precision.

About Riverside Partners:
Founded in 1989, Riverside Partners is a middle market private equity firm currently investing Riverside Partners Fund V, L.P. The fund focuses on growth-oriented companies primarily in the healthcare and technology industries.  Riverside Partners is particularly experienced at partnering with founders, owners and management teams and it brings substantial domain expertise and operating experience to its portfolio companies.  Today, Riverside Partners manages $1 billion of equity capital and seeks to make investments in companies with revenues between $20 and $200 million and with $5-$25 million of EBITDA.  For more information, please visit www.riversidepartners.com.


'/>"/>
SOURCE Tegra Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Practice Fusion Launches API to Democratize Lab Integrations
3. Viztek Announces Availability of Opal-Mammo Integrated Mammography Suite - Complete Womens Health Package Combines PACS and Tracking Software
4. Tegra Medical Announces New President/CEO
5. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
6. ClearCanvas Partners With DPR to Offer CaseReaderâ„¢, an Integrated Technology Structured Reporting Solution for Medical Imaging Professionals
7. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
8. Frost & Sullivan: Developing Integration Capabilities Presents a Real Opportunity for Vendors in the European CIS Market
9. One Year After TomoTherapy Acquisition, Accuray on Track to Meet or Exceed Integration Success Metrics And Expecting Near-term Return to Profitability
10. Ultra Clean Holdings, Inc. Completes Strategic Merger with Advanced Integration Technologies
11. Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology:
(Date:6/24/2017)... Tampa, Fla. (PRWEB) , ... June 24, 2017 ... ... Fla., is now offering genetic testing for medications in select Florida and Texas ... of pharmacogenomics. , This new application of genetic testing recognizes the role ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island ... Care Management Alerts and Dashboards, an innovative new service enabling healthcare providers to ... Care Management Alerts and Dashboards provide near real-time data about patients admitted to ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Military Officers Association of America (MOAA) announced ... Veterans Affairs, retired Marine Col. Thomas G. Bowman. , Bowman currently serves as the ... an intimacy with the issues and challenges veterans face with the VA. Following a ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... The Aesthetic ... facelift . Dr. Talei has come up with a proprietary technique that he calls ... lifts tissues that have dropped. For all ages, patients can expect to look refreshed, ...
(Date:6/23/2017)... Santa Monica, CA (PRWEB) , ... June 23, 2017 , ... ... PureLife as the endorsed amalgam separator supplier for CDA members. As part of the ... a reduced price of $99, saving more than $400 off the retail value. This ...
Breaking Medicine News(10 mins):